Tony Hitchcock
Technical Director, Cobra Biologics, a Charles River Company
When
22nd Sep 2021
Where
Webinar
Date: 22 September 2021
Time: New York – 10:00 | London – 15:00 | Paris – 16:00 | Singapore – 22:00
Duration: 75 minutes
Event structure: 10-min introduction + 45-min panel discussion + 20-min Q&A
Registration fee: Complimentary access
Webinar on-demand: Available to view until midnight 8th October 2021 (registration is required)
2020, the year of the SARS-CoV-2 pandemic, has accelerated unique global collaboration between academia, government, biotech, pharma, and the manufacturing industry, leading to scientific breakthroughs and advanced medicines being produced at unprecedented speed. How has this been possible and what can we learn from our experiences? In this webinar, contract development and manufacturing organisation Cobra Biologics, now a Charles River company, is joined by special guests to discuss.
Discussion points:
Sponsored by:
Moderator:
Tony Hitchcock
Technical Director – Cobra Biologics, a Charles River Company
Panelists:
Philip Ridley-Smith
Sales and Marketing Director – Cobra Biologics, a Charles River Company
Prof. Matti Sällberg
Head of Department of Laboratory Medicine – Karolinska Institute
Byron Rees
Senior SLS Manager – Pall Life Sciences
Dr. Alexander (Sandy) Douglas
Research Group Leader – Jenner Institute, University of Oxford
Cobra Biologics: A Charles River Company
Cobra Biologics, now a Charles River company, is a leading international contract development and manufacturing organization (CDMO) specializing in premium plasmid DNA and viral vector services to support the Advanced Therapy Medicinal Products (ATMP) industry.
Each of our GMP approved facilities are tailored to serving clients from early stage, to clinical, to commercial scale. Our team takes pride in manufacturing excellence and supporting drug development for the benefit of patients worldwide.
Our mission is to continue to expand and cultivate our CDMO offerings in the cell and gene therapy space, providing supply chain simplification through an end-to-end service for development, testing, and manufacturing. We provide our clients with an integrated solution from basic research and discovery through to GMP production.
With over a decade of experience in hosting life science events, Global Engage is your ideal partner to either devise an agenda for you or work with you and your speakers to promote the online event to our extensive databases.
For further details please contact
Gavin Hambrook
Telephone +44 (0) 7538 368 764 or
email [email protected]
Reuben Raj
Telephone: +603 2117 5193 or
email [email protected]
